Clarity Pharmaceuticals to present at Leading Nuclear Medicine conference
Sydney, Australia 9 June 2017 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce the presentation of their poster at the upcoming 2017 Annual Meeting of Society for Nuclear Medicine and Medical Imaging (SNMMI) in Denver. Clarity’s Head of Quality, Dr Colin Biggin (also with RNT consulting),…